Yes, targeting the sumoylation pathway has therapeutic potential. Inhibitors of sumoylation enzymes are being researched as potential treatments for cancers and viral infections. These inhibitors can modulate the sumoylation status of key regulatory proteins, thereby influencing disease progression.
